title: Obesity: is it a major risk for developing aspirin resistance in older adults?
authors.forename: Refaee M
authors.initials: RM
authors.lastname: Ahmed
authors.forename: Mousa S
authors.initials: MS
authors.lastname: Moustafa
authors.forename: Khater M
authors.initials: KM
authors.lastname: Shawky
authors.forename: Nabih E
authors.initials: NE
authors.lastname: Samir
authors.forename: Hassan A
authors.initials: HA
authors.lastname: Nour El Din
authors.forename: El Banouby M
authors.initials: el BM
authors.lastname: Hassan
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D004351:Drug Resistance; D004534:Egypt / Q000453:epidemiology; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology*; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin